Abeona Therapeutics (ABEO) Debt to Equity: 2011-2025
Historic Debt to Equity for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to $0.12.
- Abeona Therapeutics' Debt to Equity fell 71.69% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.12, marking a year-over-year decrease of 71.69%. This contributed to the annual value of $0.43 for FY2024, which is N/A change from last year.
- Abeona Therapeutics' Debt to Equity amounted to $0.12 in Q3 2025, which was down 3.54% from $0.12 recorded in Q2 2025.
- Abeona Therapeutics' 5-year Debt to Equity high stood at $0.72 for Q3 2022, and its period low was -$2.04 during Q1 2024.
- For the 2-year period, Abeona Therapeutics' Debt to Equity averaged around -$0.04, with its median value being $0.25 (2024).
- Data for Abeona Therapeutics' Debt to Equity shows a peak YoY increase of 122.89% (in 2025) and a maximum YoY decrease of 71.69% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Abeona Therapeutics' Debt to Equity stood at $0.20 in 2021, then dropped by 21.79% to $0.16 in 2022, then reached $0.43 in 2024, then plummeted by 71.69% to $0.12 in 2025.
- Its Debt to Equity was $0.12 in Q3 2025, compared to $0.12 in Q2 2025 and $0.47 in Q1 2025.